WeSearch

STAT+: Immunovant shares surge on arthritis trial data

Meghana Keshavan· ·1 min read · 0 reactions · 0 comments · 26 views
STAT+: Immunovant shares surge on arthritis trial data

Trial results for Lilly's "triple-G" drug, FDA's leadership purge leaves chaos, and more biotech news from The Readout

About this source

STAT News files mainly under health. We currently carry 208 of its stories.

All STAT News coverage →
Original article
STAT · Meghana Keshavan
Read full at STAT →
Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from STAT

STAT+: Up and down the ladder: The latest comings and goings
STAT+: Up and down the ladder: The latest comings and goings
STAT·5
 There are already more U.S. measles cases this year than in all of 2025
There are already more U.S. measles cases this year than in all of 2025
STAT·4
 FDA advisory panel narrowly rejects compounding of one peptide, backs two others
FDA advisory panel narrowly rejects compounding of one peptide, backs two others
STAT·5
 Opinion: I led the FDA’s food safety and nutrition center. Here’s what people are missing about the cyclospora outbreak
Opinion: I led the FDA’s food safety and nutrition center. Here’s what people are missing about the cyclospora outbreak
STAT·4
 White House offers its science blueprint: More AI, less life sciences
White House offers its science blueprint: More AI, less life sciences
STAT·4
 Opinion: The U.S. pharmaceutical supply chain problem is not about China
Opinion: The U.S. pharmaceutical supply chain problem is not about China
STAT·9